Stomach pain: when it’s serious

Stomach pain is a listed side effect, but the NHS lists an inflamed pancreas, with severe pain in your stomach or back that does not go away, among the serious ones. Mounjaro’s, Wegovy’s and Ozempic’s leaflets say stop the medicine and seek urgent medical help for severe, persistent stomach pain.

Severe pain that won’t go away

In their own words

What each leaflet and label says to do about severe stomach pain, quoted as written.

MedicineSevere stomach pain
MounjaroStop using this medicine and seek urgent medical help if you experience: Severe, persistent pain in the stomach area (abdomen), with or without nausea and vomiting.Mounjaro KwikPen patient leaflet
ZepboundStop using ZEPBOUND and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting.Zepbound prescribing information
WegovyStop using this medicine and seek urgent medical help if you experience: Severe, persistent pain in the stomach area (abdomen), with or without nausea and vomiting.Wegovy FlexTouch patient leaflet
OzempicStop using this medicine and seek urgent medical help if you experience: Severe, persistent pain in the stomach area (abdomen), with or without nausea and vomiting.Ozempic patient leaflet
RybelsusStop using this medicine and seek urgent medical help if you experience: Severe, persistent pain in the stomach area (abdomen), with or without nausea and vomiting.Rybelsus 3, 7 and 14mg patient leaflet

What the NHS lists

The serious side effects on the NHS pages that can cause stomach pain, in its words.

Side effectAs the NHS describes itListed for
An inflamed pancreasan inflamed pancreas (acute pancreatitis), which can cause severe pain in your stomach or back, which does not go awayNHS: TirzepatideSemaglutide and tirzepatide
Gallstones or gallbladdergallstones or swelling of the gallbladder (cholecystitis), which can cause severe tummy painNHS: TirzepatideTirzepatide

Also in the sources

  • Gallbladder signs

    Zepbound’s label lists signs to tell your provider about: upper stomach pain, fever, yellow skin or eyes, clay-colored stools.

  • Bowel obstruction

    Wegovy, Ozempic and Rybelsus list bowel obstruction: a severe form of constipation, with stomach ache, bloating or vomiting.

  • Everyday stomach pain

    Stomach pain is common with tirzepatide, the NHS says. Severe pain that does not go away is different: see above.

  • Had pancreatitis before?

    The leaflets ask you to tell your doctor if you’ve had pancreatitis; Zepbound’s label asks about pancreas problems.

Questions

Is stomach pain normal on these medicines?

Stomach pain is on the NHS’s common list for tirzepatide, and the Mounjaro, Wegovy, Ozempic and Rybelsus leaflets list it too. The NHS says speak to a pharmacist or doctor if a side effect bothers you; severe pain that won’t go away is the urgent case below.

When is it urgent?

Mounjaro’s, Wegovy’s, Ozempic’s and Rybelsus’s leaflets say stop the medicine and seek urgent medical help for severe, persistent stomach pain. The NHS says call 111 if you think you might be having serious side effects.

Can the pain go through to the back?

Yes, the sources say. The NHS describes severe pain in your stomach or back, and Zepbound’s label says sometimes you may feel the pain from your abdomen to your back.

Jabwise Pro

Show your doctor what you’ve logged.

Jabwise’s report for your GP or doctor brings your doses, weight and recorded side effects together in one PDF.

Jabwise Share Progress with For My GP selected, a one-month range, a five-page report preview and a Share PDF button

Sources

General information, not medical advice. Follow your prescriber’s guidance.

Getting real advice

We’re not doctors. This page sums up what the NHS and the official medicine information say, and can’t tell you what’s right for your body: your prescriber’s instructions and the leaflet in your box come first. More in our terms.

  • Quoted from official sources, each one linked
  • Sources checked 12 October 2026
  • No dosing advice; your prescriber comes first